BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6148929)

  • 1. Treatment outlines for schizophrenia.
    Aust N Z J Psychiatry; 1984 Sep; 18(3):287-9. PubMed ID: 6148929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early detection and treatment of schizophrenia].
    Hasan A; Falkai P; Wobrock T
    MMW Fortschr Med; 2010 Mar; 152(9):53-5. PubMed ID: 20384099
    [No Abstract]   [Full Text] [Related]  

  • 3. Clozapine-risperidone combination in treatment-resistant schizophrenia.
    Raju ; Kumar R; Khanna S
    Aust N Z J Psychiatry; 2001 Aug; 35(4):543. PubMed ID: 11531741
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
    Deurell M; Weischer M; Pagsberg AK; Labianca J
    Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic principles for differential therapy of psychoses].
    Hell D; Bridler R
    Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential lower efficacy of molindone among first-generation antipsychotics.
    Waugaman RM
    Am J Psychiatry; 2009 Apr; 166(4):491; author reply 492-3. PubMed ID: 19339370
    [No Abstract]   [Full Text] [Related]  

  • 8. [Associated psychotropic drugs in deficit schizophrenia].
    Beaufils B
    Encephale; 1996 Jun; 22 Spec No 2():41-3. PubMed ID: 8767041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
    Lombertie ER; Durelle G; Fuseau A
    Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acute treatment of schizophrenia].
    Wobrock T; Falkai P; Pajonk FG
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):705-23; quiz 724-6. PubMed ID: 15580535
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of treatment effects in schizophrenia.
    Stroup TS
    Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination antipsychotic therapy for the treatment of schizophrenia.
    Tapp A; Kennedy A; Kilzieh N; Rosengren K; Wood A
    Essent Psychopharmacol; 2004; 6(1):1-11. PubMed ID: 15612650
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic treatment of adolescent and child schizophrenia.
    Young CM; Findling RL
    Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinson's disease masked by clozapine: a case report.
    Zullino DF; Rodondi PY
    Gen Hosp Psychiatry; 2004; 26(4):333-4. PubMed ID: 15234830
    [No Abstract]   [Full Text] [Related]  

  • 19. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward.
    Hellewell JS
    J Clin Psychiatry; 1999; 60 Suppl 23():14-9. PubMed ID: 10625195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.